UNID Co. Ltd. Overview
UNID is the world's largest producer of industrial potassium chemicals, principally potassium hydroxide (KOH, caustic potash) and potassium carbonate (K₂CO₃). It makes them by electrolysing imported potassium chloride (KCl) in membrane chlor-alkali cells. Its manufacturing base spans Ulsan, South Korea, and three Chinese sites (UJC and OJC in eastern China, and UHC in Yichang, Hubei). Consolidated KOH-equivalent capacity was about 810,000 tonnes a year after the 2024–25 expansions. The Korean business is export-oriented, with roughly 77–90% of sales shipped overseas, mainly to Asia, India, Europe and Latin America. The Chinese business sells mostly into China's domestic market. End markets include potash fertilisers (potassium phosphates and nitrates), agrochemicals, food additives, pharmaceuticals, rubber latex, glass, solar cells, and carbon capture via the hot-potassium-carbonate process. Co-products such as chlorine, hydrochloric acid, hypochlorite and hydrogen are a structural earnings swing factor. The stock trades at about 0.35x book, a historical trough.
Company self-description
UNID describes itself as a potassium-based chemicals specialist. In investor materials, it presents itself as the global market-share leader in potassium chemicals. Its product slate covers:
-
potassium hydroxide (liquid and solid/flake);
-
potassium carbonate;
-
chlor-alkali co-products: hydrochloric acid, liquid chlorine, sodium hypochlorite, ferric/ferrous chloride and hydrogen;
-
in China, chlorinated paraffin wax (CPs), a downstream chlorine-consuming product.
The company lists its applications as:
-
agricultural pesticides;
-
petrochemicals;
-
fertilisers;
-
pharmaceuticals;
-
SBR/NB latex;
-
solar cells;
-
plastic polymerisation promoters;
-
animal feed;
-
gas refining;
-
glass;
-
food additives;
-
household bleach;
-
metal surface treatment;
-
water treatment.
Independent characterisation
UNID is best understood as a spread business on the KOH/K₂CO₃–KCl differential, with a chlorine by-product overlay. Electrolysing one tonne of KCl yields KOH plus roughly 0.6 tonnes of chlorine and some hydrogen. The economics therefore depend on four variables:
-
The potassium chain spread. Selling prices for KOH and K₂CO₃ track potash (KCl) prices with a lag, so the spread widens when KCl prices rise and buyers stockpile. Brokers measure this as a one-month-lagged spread.
-
Chlorine realisation. This matters most in China, where chlorine prices were negative for long periods. Jiangsu chlorine was about –750 yuan/t in early 2025, averaged about –132 yuan/t in 2025, and spiked to about +300 yuan/t on 21 January 2026 (Hana, January 2026). Hana estimates that each +100 yuan/t move in chlorine adds about KRW 5 bn to annual operating profit.
-
Electricity costs. Electricity is the dominant conversion cost of electrolysis. Korean industrial tariff hikes have repeatedly hurt third-quarter results.
-
Ocean freight and FX. Most Korean output is exported. Freight spikes, such as the 2Q26 Iran-war-related surge, compress margins, and a weaker won helps them.
Business and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | ~100% product sales of commodity and specialty inorganic chemicals; no meaningful service, subscription or licensing revenue |
| Value-chain position | Midstream converter: buys KCl (largely Canadian potash, e.g. Canpotex, per IBK) and sells potassium derivatives to fertiliser formulators, chemical processors, food and pharma companies, and glass and rubber makers |
| Customer types | Industrial B2B: specialty-fertiliser producers (potassium phosphate/nitrate), agrochemical formulators, food processors, pharmaceutical firms, latex/rubber makers, glass and solar producers, water-treatment operators, gas-treating/CCS operators |
| Geographic model | Korea entity exports (~77% of 2023 sales per Hanwha; ~90% export share cited by UNID in July 2024 press). China entities sell overwhelmingly domestically (Hana, April 2025) |
| US exposure | ~7% of Korea-entity sales go to the US (Hana, April 2025), limiting tariff exposure |
| Cyclicality | Linked to the potash cycle, agricultural demand, and industrial demand in China and India |
| Seasonality | Typically stronger in the first half and weaker in the second (상고하저): Q2 is the peak season, while Q3 suffers higher Korean summer power tariffs and Chinese chlorine weakness, and Q4 carries annual maintenance |
End-markets served
| End-market | Products | Commentary |
|---|---|---|
| Specialty fertilisers / agriculture | KOH, K₂CO₃ | Largest growth driver; potassium phosphate and nitrate production; demand from India and Latin America cited repeatedly by brokers |
| Agrochemicals | KOH | Pesticide synthesis |
| Food and feed | KOH, K₂CO₃ | Food additives, animal feed |
| Pharmaceuticals | KOH | Reagent and synthesis |
| Rubber / latex | KOH | SBR/NB latex (including glove-latex chains) |
| Glass, solar and electronics | K₂CO₃, KOH | Specialty glass, solar-cell texturing/cleaning |
| Gas treating / carbon capture (CCS) | K₂CO₃ | Hot-potassium-carbonate (Benfield-type) CO₂ capture; brokers frame CCS as a medium-term re-rating option |
| Water treatment / bleach | NaOCl, ferric chloride, HCl | Domestic co-product outlets |
| PVC/plasticiser chain (China) | CPs | Chlorine sink in China; plant operating since 2H24 |
Strategy
Stated strategic themes (company IR and press)
-
Capacity leadership in potassium chemicals. Expand KOH capacity in Korea and China to defend global number-one status: the Ulsan 1st and 2nd expansions, and UHC from 90kt to 180kt.
-
China inland penetration. Use Yichang to move beyond the eastern coastal base into central and western China (Guangdong, Chongqing, Sichuan, Jiangxi).
-
Chlorine monetisation. Use downstream sinks, chiefly CPs in China, to reduce exposure to negative chlorine prices.
-
Product diversification. Expand light potassium carbonate (30kt to 50kt at Yichang), develop CCS-grade carbonate, and conduct exploratory work on solid-state electrolytes and hydrogen sensors.
-
Shareholder value. Maintain unbroken profitable dividends, raise DPS (KRW 1,600, then ~1,800, then 2,000), and adopt Korea's "Value-up"-era dividend reforms (record date set after the dividend announcement).
-
Organisational renewal. Management characterised the November 2023 reshuffle as aimed at youthful leadership and a culture shift.
Initiative register (last 24 months)
| Initiative | Date | Target / status |
|---|---|---|
| Ulsan electrolyser expansion | Jul 2024 | 400kt to 480kt cell capacity; complete |
| China CPs plant | 2H24 | Commercial operation; start-up losses through 2025 |
| UHC phase 1 (90kt) | Jan–Feb 2025 | Full operation; completion ceremony 17 April 2025 |
| Yichang light K₂CO₃ | 2,025 | Investment under way (March 2025 IR) |
| UHC phase 2 (90kt) | 2026 construction | Completion 2H26 (iM, October 2025) or 2027 (press and iM, July 2026); conflicting |
| Dividend-procedure reform | Feb 2026 | Record date 31 March, set after the announcement |
Management guidance
Explicit medium-term financial targets (revenue, margin or ROE) are not disclosed. Operational guidance for 2H26, given on 22 July 2026, is as follows:
-
Domestic utilisation rising from 68% in 2Q26 to 90–95% in 2H26.
-
Domestic sales volume up 4–6% versus 1H26.
-
China potassium sales volume up 2–3% versus 1H26.
Products & Services
Product-level pricing is not disclosed. UNID sells on negotiated contract and spot terms indexed loosely to potash and regional caustic markets.
Domestic Chemicals (Ulsan)
| Product | Description / specification | Key applications | Target customers | Notes |
|---|---|---|---|---|
| Potassium hydroxide, liquid (KOH ~48%) | Aqueous caustic potash, membrane grade | Fertiliser salts, chemicals, latex, food, pharma | Fertiliser and chemical processors in Asia | Largest volume product; shipped in ISO tanks and bulk |
| Potassium hydroxide, solid/flake (KOH ~90%) | KOH 90% / water 10% flakes | Export markets where liquid freight is uneconomic | India, Southeast Asia, Latin America, Europe | Indian import records explicitly cite UNID-manufactured KOH 90% (Volza, June 2025) |
| Potassium carbonate (K₂CO₃) | Granular and powder grades, produced by carbonating KOH | Specialty glass, solar, food, gas treating/CCS, potassium silicate | Glass, solar, food and gas-treating customers | Strong export growth noted in 2Q24 |
| Hydrochloric acid (HCl) | Co-product of the chlorine stream | Metal pickling, chemical synthesis, water treatment | Korean industrial users | Domestic co-product |
| Liquid chlorine (Cl₂) | Electrolysis co-product | PVC, chemicals, water treatment | Korean chemical complexes (Ulsan) | Pricing a margin swing factor |
| Sodium hypochlorite (NaOCl) | Bleach solution | Household bleach, disinfection, water treatment | Utilities and consumer-goods producers | Chlorine sink |
| Ferric / ferrous chloride | Iron chloride solutions | Water and wastewater coagulant | Municipal and industrial water treatment | Chlorine sink |
| Hydrogen (H₂) | Electrolysis co-product | Industrial fuel and feedstock | Neighbouring industrial users | Not separately quantified |
China Chemicals (UJC, OJC, UHC)
| Product / asset | Description | Applications | Notes |
|---|---|---|---|
| KOH (UJC/OJC, eastern China) | Liquid and solid KOH | Chinese domestic fertiliser, chemical and new-energy chains | Sales concentrated near the plants because of liquid logistics and regulation (IBK) |
| KOH (UHC, Yichang, Hubei) phase 1 | 90kt/yr; trial January 2025, full operation February 2025 | Inland China: Guangdong, Chongqing, Sichuan, Jiangxi | Part of the KRW 230 bn, 180kt Yichang project |
| KOH (UHC) phase 2 | Additional 90kt/yr | Same as phase 1 | Timing conflict: iM (October 2025) said early completion in 2H26; press (April 2025) and iM (July 2026) reference 2027 |
| Light potassium carbonate (Yichang) | Expanded from 30kt to 50kt at the Yichang project | Glass, food, electronics | Diversification product (IBK, August 2024) |
| Chlorinated paraffin wax (CPs) | ~KRW 63 bn plant; trial April 2024, commercial 2H24 | PVC plasticiser, flame retardant, lubricant additive | Built to absorb surplus chlorine; incurred start-up losses of ~KRW 3 bn in 4Q24 |
| Chlorine and derivatives | Co-product | Chinese PVC/epoxy chains | Chlorine prices below zero for much of 2024–25 |
Development-stage and R&D products
| Area | Status | Source |
|---|---|---|
| Potassium carbonate for CCS solvents | Market-development theme; no named contract disclosed | Hanwha, June 2024; Hi Investment, April 2024 |
| Solid-state battery electrolyte materials | Cited as a new growth driver; no commercial product disclosed | Hi Investment, April 2024 |
| Hydrogen sensing (hydrogen-selective, flexible tape) | Korean national R&D project in 2023 | THE VC |
Financial Narrative
Income statement
Sources and notes:
-
FY2021–FY2023: SK Securities (January 2025).
-
FY2024: Hana (February 2025) and Samsung (October 2025); EPS from iM.
-
FY2025 revenue is the sum of the provisional quarters: 322.5 + 340.9 + 329.0 + 346.3. OP is from iM and Hana (April 2026); net income is from Hana (April 2026), with DS citing KRW 65 bn.
FY2025 EPS (KRW 9,650) is an analyst-derived approximation: (KRW 65.3 bn ÷ ~6.77m shares) and is not a reported figure. Verify against the DART annual report.
- FY2021 net income includes the then-board division and one-off gains, so it exceeds operating profit.
Revenue CAGR FY2021–FY2025: ~11.3% a year. This is flattered by the low FY2021 restated base. CAGR FY2022–FY2025 is –1.6% a year, reflecting the 2023 potash normalisation.
Brokers cite EV/EBITDA multiples of 4.2x (2021), 4.1x (2022) and 6.4x (2023) (SK), which implies EBITDA well above operating profit given heavy depreciation on cell-house assets. Absolute EBITDA: n/v. Diluted EPS is expected to equal basic EPS because no dilutive instruments are known: n/v.
Quarterly income statement
Sources and notes:
- Quarterly figures are company provisional disclosures, as reported by SmartToday, Hana, Samsung, ETFShopping, DS and Bizwatch.
2Q26 net income: KRW 43.1 bn (+81.1% YoY) per the provisional disclosure. Non-operating gains appear to account for the gap versus operating profit; the composition (e.g. FX gains) is n/v.
1H26: revenue KRW 784.2 bn (+18% YoY), operating profit KRW 49.7 bn (–19% YoY), net income ~KRW 68.0 bn.
Balance sheet
Sources and notes:
-
Current assets, current debt and FY2022–FY2023 liabilities: Hanwha (April and July 2024) and SK (January 2025).
-
Inventories: Hana (January 2026).
-
FY2024 total liabilities is an SK estimate published January 2025 (prior to the audited figure).
Total assets (iM Securities):
-
FY2024: KRW 1,365 bn
-
FY2025: KRW 1,524 bn
-
FY2026E: KRW 1,645 bn
Equity: Book value per share is ~KRW 160–170k. iM uses a 2026E BPS of KRW 170,552; ValueLine's PBR of 0.34x at KRW 62,000 implies BPS of ~KRW 182k, which likely includes minority interests. Total equity is therefore roughly KRW 1.1–1.2 trillion (n/v precisely).
Retained earnings: KRW 1,156 bn (FY2025E/A basis per iM, April 2026).
IBK reports intangible assets of only ~KRW 5–12 bn, so goodwill is immaterial. Hanwha cited UNID Global Trading at 45.6% and current interest-bearing debt flat at KRW 182 bn in its forecasts. DS shows non-current liabilities rising from ~KRW 48 bn (2023) to ~KRW 135 bn (2024), consistent with long-term borrowing to fund Yichang.
Cash flow
The disclosed capital programme is as follows:
Dividends paid:
-
FY2023 DPS of KRW 1,600, ~KRW 10.6 bn in total
-
FY2025 DPS of KRW 2,000, ~KRW 13.3 bn in total
Buybacks: no programme disclosed in the reviewed period beyond the CEO's personal purchase (August 2023).
Operating cash flow, capex by year and free cash flow are n/v.
Ratios
Sources and notes:
-
FY2021–FY2023: SK (January 2025).
-
FY2024 and FY2025: SK and broker estimates, plus ValueLine (ROE of 5.86% on a trailing basis, July 2026).
-
FY2024–FY2025 values are approximations from broker estimates and trailing data, not company-reported ratios.
ROA, ROIC, current ratio, debt/equity, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle are n/v from primary filings. Indicatively, total liabilities of ~KRW 386 bn against equity of ~KRW 1.1 trillion implies liabilities/equity of roughly 0.35x, a conservatively financed balance sheet.
Commentary on trends, inflections and drivers
-
Supercycle and normalisation (2021–2023). Potash prices spiked after the Belarus sanctions in 2021 and the Russia–Ukraine war in 2022. Because UNID passes KCl costs through with a lag, revenue rose 60% in 2022 to KRW 1,405 bn, while OP held at ~KRW 148 bn. As KCl prices collapsed in 2023, selling prices fell faster than inventory cost, and Chinese chlorine went deeply negative. OP fell 78% to KRW 32 bn and ROE dropped to 1.8%.
-
Recovery (2024). Raw-material stabilisation and European and agricultural demand lifted OP almost threefold to KRW 95.4 bn. A weak won helped further, since about 77% of sales are exports. 4Q24 one-offs totalled about KRW 12 bn of start-up costs plus a bonus and maintenance, broken down as follows:
-
Volume growth without margin (2025). Revenue rose 20% to KRW 1,339 bn on UHC volumes and higher KOH prices, which followed China's KCl tightness. OP nonetheless declined 8% to KRW 87.9 bn. The main causes were weak 2H25 domestic profitability, Chinese chlorine losses, customer destocking and 4Q maintenance. Freight savings of KRW 40–50 bn year-on-year, forecast by IBK in April 2025, were only partly realised.
-
Record revenue with profit compressed by freight (1H26). Record Q1 and Q2 revenue reflected structurally tight potash markets amid the Russia–Ukraine and Iran conflicts. Margins compressed on freight, and on lower chlorine offtake as customer plants cut runs. Net income rebounded sharply in 2Q26 (KRW 43.1 bn) on non-operating items.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Legal entities / sites | Products | Commentary |
|---|---|---|---|
Domestic Chemicals (국내화학) | UNID Co., Ltd., Ulsan plant | KOH (liquid/solid), K₂CO₃, HCl, liquid chlorine, NaOCl, ferric/ferrous chloride, hydrogen | Export-led; electrolyser capacity ~480kt after the July 2024 expansion |
China Chemicals (중국화학) | UJC and OJC (eastern China), UHC (Yichang, Hubei) | KOH, K₂CO₃ (including light K₂CO₃ at Yichang), chlorine and derivatives, CPs | Mostly Chinese domestic sales; China KOH capacity about 320kt, then ~410kt in 2025 and a 500kt target for 2027 |
Discontinued: Board (MDF) | Now UNID BTPlus (KOSPI 446070) | MDF, particleboard, formalin, lumber | Separated in 2H22; UNID BTPlus reported 2025 revenue of KRW 157.5 bn and an operating loss of KRW 9.2 bn (ButlerWorks) |
Revenue by Segment
| Segment | FY2023 | FY2024 |
|---|---|---|
Domestic Chemicals revenue (KRW Bn) | 645.8 | 609.3 |
China Chemicals revenue (KRW Bn) | 526.5 | 521.9 |
Consolidated revenue (KRW Bn) | 1,133.7 | 1,111.6 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (FY2023–FY2025)
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Domestic Chemicals OP (KRW Bn) | 29.6 | 59.6 | 55.4 |
China Chemicals OP (KRW Bn) | 0.1 | 34.0 | 29.4 |
Consolidated OP (KRW Bn) | 32.1 | 95.4 | 87.9 |
Segment Overview — Domestic Chemicals OP
| Segment | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|
Domestic Chemicals OP (KRW Bn) | 18.7 | 20.2 | 12.4 | 4.1 | 12.3 | 11.2 |
China Chemicals OP (KRW Bn) | 9.2 | 11.9 | 5.7 | 2.6 | 12.3 | 13.0 |
Consolidated OP (KRW Bn) | 28.7 | 32.8 | 18.8 | 7.6 | 25.5 | 24.2 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 877 | 1,405 | 1,133.7 | 1,111.6 | 1,338.7 |
Operating profit (KRW Bn) | 149 | 148 | 32.1 | 95.4 | 87.9 |
Net income attributable to owners (KRW Bn) | 183 | 124 | 16.3 | 76.2 | 65.3 |
EPS basic (KRW) | 18,905 | 17,612 | 2,403 | 11,265 | 9,650 |
Operating margin (%) | 17.0 | 10.5 | 2.8 | 8.6 | 6.6 |
Net margin (%) | 20.9 | 8.8 | 1.4 | 6.9 | 4.9 |
Financial Analysis
| Metric | 1Q24 | 2Q24 | 3Q24 | 4Q24 | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 254.7 | 291.6 | 289.8 | 275.5 | 322.5 | 340.9 | 329.0 | 346.3 | 384.4 | 399.8 |
Operating profit (KRW Bn) | 27.5 | 35.0 | 20.5 | 10.1 | 28.7 | 32.8 | 18.8 | 7.6 | 25.5 | 24.2 |
Net income (KRW Bn) | 21.7 | 27.1 | 19.8 | 12.1 | 22.3 | 23.8 | 16.8 | 1.9 | 24.9 | 43.1 |
Operating margin (%) | 10.8 | 12.0 | 7.1 | 3.7 | 8.9 | 9.6 | 5.7 | 2.2 | 6.6 | 6.1 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
Current assets (KRW Bn) | 849 | 570 | 562 |
Inventories (KRW Bn) | 293.8 | 137.4 | 138.4 |
Current interest-bearing debt (KRW Bn) | 397 | 182 | 182 |
Total liabilities (KRW Bn) | 588 | 356 | 386 |
Capital Programmes
| Programme | Capex (KRW Bn) | Period |
|---|---|---|
Yichang (UHC) project, 2 × 90kt KOH plus light K₂CO₃ | ~230 (total, both phases) | 2023–2027 |
China CPs plant | ~63 | 2023–2024 |
Ulsan electrolyser expansion (400kt to 480kt cell capacity) | n/v | 2023–2024 |
Returns & Leverage Ratios (%) and Valuation Multiples (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 20.5 | 13.1 | 1.8 | 8.9 | 5.9 |
PER (x, year-end basis) | 5.3 | 4.6 | 28.2 | 5.9 | 6.5 |
PBR (x) | 0.9 | 0.6 | 0.5 | 0.5 | 0.4 |
EV/EBITDA (x) | 4.2 | 4.1 | 6.4 | 3.9 | 4.0 |
4Q24 One-off Item Details
| 4Q24 one-off item | Approximate cost (KRW Bn) |
|---|---|
Head-office bonus | 3 |
Power tariffs | 2 |
UHC start-up costs | 2 |
CPs losses | 3 |
Maintenance and lost sales | 3–5 |
Dimension Details
| Dimension | Data point | Source / year |
|---|---|---|
Export share of revenue | ~77% of FY2023 revenue | Hanwha, April 2024 |
Export share (company statement) | ~90% | UNID via SmartToday, July 2024 |
China entities | Overwhelmingly Chinese domestic sales | Hana, April 2025 |
US share of Korea-entity sales | ~7% | Hana, April 2025 |
Korea-entity key markets | India, Southeast Asia (Vietnam, Indonesia), Turkey, USA, Europe, Latin America | Preqin; Hanwha; Hi Investment |
Growth markets cited | India (agricultural), Europe (2024), Latin America; inland China (Yichang) | Hi Investment; IBK; Hankyung |
Revenue by Region
| Region proxy | FY2023 | FY2024 |
|---|---|---|
Korea-entity sales, mostly exported (KRW Bn) | 645.8 | 609.3 |
China-entity sales, Chinese domestic (KRW Bn) | 526.5 | 521.9 |
Share Price & Returns
| Date | Close (KRW) | Source |
|---|---|---|
24 Apr 2024 | 87,900 | Hanwha |
5 Jun 2024 | 112,100 | Hanwha |
8 Apr 2025 | 70,100 | iM |
28 May 2025 | 87,200 | iM |
9 Jul 2025 | 92,000 | iM |
24 Nov 2025 | 63,900 | DS |
22 Apr 2026 | 85,900 | iM |
27 May 2026 | 70,500 | DS |
22 Jul 2026 | 59,000 | iM |
29 Aug 2026 | 66,500 | Investing.com |
Valuation Snapshot
| Multiple | Value | Basis / source |
|---|---|---|
P/E (trailing) | 5.89x | ValueLine, 23 July 2026 |
P/B (trailing) | 0.34x | ValueLine, 23 July 2026 |
P/B | ~0.35x, a historical low | iM, July 2026 |
ROE (trailing) | 5.86% | ValueLine, 23 July 2026 |
EV/EBITDA | n/v (current) | — |
EV/Sales | n/v (current) | — |
Analyst Ratings & Targets
| Broker | Date | Rating | Target price (KRW) | 2026E OP (KRW Bn) |
|---|---|---|---|---|
iM Securities | 23 Jul 2026 | Buy | 85,000 (from 110,000) | 101.3 |
DS Investment | 28 May 2026 | Buy | 100,000 | 127 |
Hana Securities | 23 Apr 2026 | Buy | n/v | 126.8 |
Samsung Securities | 30 Oct 2025 | Buy | 93,000 | 113 (at that date) |
Investing.com consensus target | Aug 2026 | Strong Buy | 95,600 | — |
Dividend History
| Fiscal year | DPS (KRW) | Total payout (KRW Bn) | Source |
|---|---|---|---|
FY2009 (approx.) | 1,000 | n/v | NewsTomato |
FY2023 | 1,600 | ~10.6 | SmartToday |
FY2024 | ~1,800 (implied by the +11% increase to 2,000) | n/v | Derived from SmartToday |
FY2025 | 2,000 | ~13.3 | SmartToday |
Analyst Conclusions
Management guidance
UNID does not issue numeric earnings guidance. Its 2H26 operational guidance (22 July 2026) is as follows:
-
Domestic utilisation rising from 68% to 90–95%.
-
Domestic volume up 4–6% half-on-half.
-
China potassium volume up 2–3% half-on-half.
-
UHC phase 2 under way for completion around 2027.
Consensus expectations
| Metric | FY2024 | FY2025 | FY2026 | FY2027 |
|---|---|---|---|---|
| Operating profit, Hana (KRW bn) | 95.4 | 87.9 | 126.8 | 135.6 |
| Operating profit, iM (KRW bn) | 95.4 | 87.9 | 101.3 | 130 |
| Net income, Hana (KRW bn) | 76.2 | 65.3 | 102.5 | 103.5 |
| Net income, iM (KRW bn) | 76.2 | 65.3 | 71 | 93 |
FY2024–FY2025 are actuals; FY2026–FY2027 are estimates. Sources: Hana (23 April 2026) and iM (23 July 2026).
Hana's figures predate the 2Q26 miss. Its 1H26 actual OP of KRW 49.7 bn implies 2H26 must deliver ~KRW 52–77 bn to meet the range of estimates.
Bull case
-
Structural potash tightness widens spreads. Restraint by Canadian and Belarusian KCl producers, low Chinese inventories and conflict-driven fertiliser stress support KOH/K₂CO₃ pricing. iM estimates the 2Q26 KOH spread widened ~20% QoQ even as OP fell on freight.
-
Volume step-up. UHC phase 2 (+90kt), a return of Ulsan utilisation to 90–95%, and record revenue already running at ~KRW 400 bn a quarter create operating leverage once freight normalises.
-
Deep value with a dividend floor. PBR of ~0.35x and P/E below 6x, combined with a ~3% yield and a rising DPS, offer asymmetric upside if ROE recovers toward the 9–10% brokers model.
Bear case
-
Margin, not volume, is the problem. Despite +20% revenue growth in FY2025, OP fell 8%, and 1H26 OP is down 19% YoY on record revenue. The growth may be accruing to suppliers, shippers and utilities.
-
Chlorine remains a structural drag. iM expects large chlorine losses in China to persist through the 2H26 off-season. The January 2026 chlorine spike proved transient.
-
Repeated earnings misses and governance discount. UNID missed consensus by 21–45% in four of the last seven quarters (3Q25, 4Q25 and 2Q26 most severely). Combined with family control and limited disclosure, this argues the low multiple may persist.
Key catalysts and monitorables (next 12 months)
| Catalyst | Timing | What to watch |
|---|---|---|
| 3Q26 results | ~2 Nov 2026 | Domestic utilisation recovery, freight normalisation, chlorine loss size |
| 4Q26 results and FY2026 DPS | Jan–Feb 2027 | Avoidance of a third consecutive weak fourth quarter; DPS above KRW 2,000 |
| UHC phase 2 progress | 2026–2027 | Construction milestones; any acceleration or slippage |
| China chlorine price | Ongoing | Jiangsu chlorine sustained above zero |
| Potash contract prices (China/India) | 1H27 | Spread trajectory |
| Middle East shipping | Ongoing | Freight-rate normalisation |
| Korea Value-up / governance | Ongoing | Buyback adoption, treasury cancellation, independent-director additions |
Analyst verdict
UNID is a well-capitalised global leader in a niche commodity: industrial potassium chemicals. It has spent the past three years adding scale, but the earnings conversion has been disappointing. The investment case rests on three facts.
First, capacity has risen about 20% to ~810kt, with a further ~90kt planned in Yichang. Revenue has responded, reaching all-time quarterly highs of ~KRW 400 bn in 2026.
Second, operating profit has not followed. FY2025 OP of KRW 87.9 bn was below FY2024 despite 20% higher sales, and 1H26 OP fell 19% year-on-year. The culprits are largely exogenous but recurring: negative Chinese chlorine values, freight shocks, Korean power costs and customer destocking. A business so exposed to factors outside management's control deserves some discount.
Third, the market has applied far more than "some" discount. At roughly 0.35x book and under 6x trailing earnings, the shares imply that ROE will stay near today's ~6% indefinitely. The balance sheet is conservatively geared, dividends have been raised every year recently, and cyclical peak earnings (2021–22) were around KRW 150 bn.
On balance, UNID screens as an undervalued, cyclically depressed asset whose re-rating depends on proof of margin recovery rather than volume growth. The next two quarters are decisive. A 3Q26 print showing domestic utilisation back above 90%, normalised freight and contained chlorine losses would validate the consensus FY2027 OP of ~KRW 130–136 bn and justify convergence toward broker targets (~KRW 85–100k). A further miss would likely confirm the bear thesis that scale is being competed away.
Governance improvements would materially narrow the discount independently of the cycle: buybacks, treasury-share cancellation, segment and geographic disclosure, and medium-term targets. Investors should treat UNID as a value-and-yield holding with cyclical optionality, sized accordingly. Monitor chlorine prices and freight rates as leading indicators ahead of each quarterly release.
Items marked "n/v" or "E" require verification against UNID's DART filings before reliance.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / background | Education | Age |
|---|---|---|---|---|
Lee Hwa-young (이화영) | Chairman | Second-generation member of the OCI founding family (son of founder Lee Hoe-rim); leads the UNID line | n/v | ~70 (Investing.com) |
Jung Eui-seung (정의승) | Vice Chairman and Co-CEO | Joined OCI management planning in 1983; moved to UNID in 2000 as executive director of management support, then senior executive director, executive vice president and CEO; promoted to Vice Chairman 30 November 2023 | Chung-Ang University, Business Administration | Born 1958 |
Lee Woo-il (이우일) | President and Co-CEO | UNID chemical division overseas sales, UNID Global Trading China and US units, head of strategic planning, executive vice president; co-CEO from March 2023; promoted to President 30 November 2023 | MBA, University of Southern California | Born 1981 |
Kim Sang-bae (김상배) | CTO | Attended the Yichang ceremony, April 2025 | n/v | n/v |
Cho Kyung-deuk (조경득) | President, China operations | Head of the China subsidiaries | n/v | n/v |
Han Sang-jun (한상준) | Former executive vice president (son-in-law of the Chairman) | Cited by Dealsite as participating in management; current role n/v | n/v | n/v |
Board of Directors
| Name | Role |
|---|---|
Lee Wha-young | Chairperson |
Jung Eui-seung | President and Director (now Vice Chairman) |
Jung Hoon-mo | Vice-President and Director |
Lee Chul | Director |
Choi Chun-geun | Independent outside director |
Lee Jong-gu | Independent outside director |
Board & Management Changes
| Date | Change |
|---|---|
Mar 2023 | Lee Woo-il appointed co-CEO |
30 Nov 2023 | Jung Eui-seung promoted to Vice Chairman; Lee Woo-il promoted to President; Kwak Hyun-chul promoted to executive director at UNID Global Trading |
Major Shareholders
| Holder | Stake | Source / date |
|---|---|---|
UNID Global Trading and 11 related parties | 46.3% | DS, May 2026 |
National Pension Service (and 1 related party) | 7.0% | DS, May 2026 |
Treasury shares | ~1.9% | Hanwha, April 2024 |
Foreign investors (aggregate) | 11.7% | DS, May 2026 |
Competitive Landscape
Key Competitors
| Competitor | Country | Segment overlap | Relative positioning versus UNID |
|---|---|---|---|
Occidental Chemical (OxyChem) | USA | KOH, K₂CO₃ | Largest in North America; vertically integrated chlor-alkali; less Asia exposure |
Olin (Chlor Alkali) | USA | KOH | Large chlor-alkali major; KOH a small share of its portfolio |
Vynova | Belgium / Europe | KOH, K₂CO₃ | Key European producer; competes in UNID's European export lanes |
Evonik | Germany | K₂CO₃, KOH | Specialty potassium salts; premium European grades |
Altair Chimica | Italy | KOH, K₂CO₃ | Mid-sized European competitor |
AGC | Japan | KOH | Japanese domestic chlor-alkali |
Toagosei | Japan | KOH | Japanese specialty chlor-alkali |
Qinghai Huixin | China | KOH | Benefits from domestic Qinghai potash resources |
Inner Mongolia Ruida Taifeng | China | KOH | Low-cost power; domestic Chinese competition |
Shandong Changyi Haineng | China | KOH, K₂CO₃ | Eastern China rival to UJC/OJC |
Huarong Chemical | China | KOH | Listed Chinese KOH producer (Sichuan); inland competitor to UHC |
Tangshan Sanfu Silicon | China | KOH, silicon chemicals | Integrated KOH producer in northern China |
ERCO Worldwide | Canada | KOH | North American niche producer |
Pan-Americana | Colombia | KOH, K₂CO₃ | Latin American regional producer |
Competitor Detail
| UNID metric | Value |
|---|---|
FY2025 revenue | KRW 1,338.7 bn |
Revenue growth (FY2025) | +20.4% |
Operating margin (FY2025) | 6.6% |
R&D intensity | n/v |
Recent Developments
Only 25 material entries were identifiable from public sources in this window.



